EPA-FFA to Treat Hospitalised Patients With COVID-19 (SARS-CoV-2)

NCT04335032 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

284

Enrollment

INDUSTRY

Sponsor class

Conditions

SARS-CoV-2

Interventions

DRUG: Eicosapentaenoic acid gastro-resistant capsules
DRUG: Placebo

Sponsor

S.L.A. Pharma AG